Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Bifidobacterium breve Rosell-70 and Improved Depressive Symptoms

Research synthesisLow evidenceModerate effect3 studies · 3 beneficial · 0 neutral · 0 harmful

Across 3 studies, all reported beneficial effects on depressive symptoms, with predominantly moderate effect sizes. Two of the three studies reported statistically significant findings. The evidence is based on broad reviews of psychobiotics and probiotics, not on direct trials of Bifidobacterium breve Rosell-70 specifically.

Caveats: The three studies are broad reviews of psychobiotics and probiotics for depression; they do not isolate the effects of Bifidobacterium breve Rosell-70 specifically. Direct evidence for this strain is lacking, and effect sizes reflect general probiotic interventions. No dose, form, or duration data were reported.

Generated May 11, 2026
3 of 3 papers
Back to top